CIK cell immunotherapy CIK cells are T lymphocytes with NK cell characteristics obtained by culturing human peripheral blood single nuclei cells in vitro with multiple cytokines, which have powerful anti-tumor activity and restricted tumor-killing characteristics.CIK cells are the preferred option for next-generation anti-tumor over-the-top immunotherapy. The indications for CIK therapy: CIK therapy is indicated for all malignant tumor patients with a survival period of more than three months, and the earlier it is applied, the better the results. the application of CIK cell therapy has covered hematologic tumors, solid tumors and hepatitis virus infectious diseases. Hematological tumors include acute and chronic leukemia, malignant lymphoma, etc.; solid tumors include liver cancer, lung cancer, gastric cancer, nasopharyngeal cancer, kidney cancer, colorectal cancer, esophageal cancer, ovarian cancer, breast cancer, etc.; viral infectious diseases include chronic hepatitis B, liver cirrhosis, hepatitis C, etc. Advantages of CIK treatment 1.Prevention of recurrence and metastasis of malignant tumors. 2.Can be combined with surgery and radiotherapy to enhance the therapeutic effect. 3.Comprehensive improvement of body immune function. 4.No toxic side effects.